New An Open Letter to Millions of U.S. Private Company Employees

Read More east close
menu close
blackrockneurotech.com/

Blackrock Neurotech Stock

Company Profile:

Blackrock Neurotech specializes in developing advanced brain-computer interface (BCI) technology that helps individuals with neurological conditions, including paralysis, regain independence. Their devices allow patients to interact with digital systems or control robotic limbs using only their thoughts. The company's innovation empowers users to perform everyday activities and access new forms of communication, offering life-changing possibilities for those with motor impairments.

Sign up for SecondMarket™ to view the market and buy or sell Blackrock Neurotech Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Blackrock Neurotech Management Team

  • Director, Co-Founder, Chief Science Officer

    Florian Solzbacher

  • Director

    Tim Sievers

  • Director, Co-Founder, CEO

    Marcus C. Gerhardt

  • CFO

    Thomas Thiele

  • Director

    Max de Vere

  • Director

    Christian Angermayer

Blackrock Neurotech Major Investors

  • Sorenson Impact Group

  • re.Mind Capital

  • Tether

Learn More About Blackrock Neurotech Stock

Buy Blackrock Neurotech Stock
01

Blackrock Neurotech stock does not trade on public stock exchanges. Blackrock Neurotech stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Blackrock Neurotech stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Blackrock Neurotech Stock
02

Blackrock Neurotech Stock does not trade on public stock exchanges. In order to sell Blackrock Neurotech shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Blackrock Neurotech Stock Price
03

Blackrock Neurotech does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Blackrock Neurotech share price and other valuable private market data.

Read more about secondary market private company stock prices:

Blackrock Neurotech Stock Ticker Symbol
04

There is no ticker symbol for Blackrock Neurotech stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Blackrock Neurotech Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Blackrock Neurotech stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Blackrock Neurotech Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Blackrock Neurotech stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Blackrock Neurotech Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Blackrock Neurotech IPO
08

Blackrock Neurotech is a private company and has not had an IPO. There is currently no Blackrock Neurotech IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Blackrock Neurotech IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Blackrock Neurotech Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Hinge Health-Logo

Hinge Health

Digital clinic for back, joint, and muscle pain.

Somatus-Logo

Somatus

integrated care for patients with or at risk of developing kidney disease.

Cityblock Health-Logo

Cityblock Health

Tech-driven care provider for communities with complex needs.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Cedar Inc-Logo

Cedar

The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

Ambience Healthcare Inc-Logo

Ambience

AI-powered solutions to improve clinical documentation and reduce clinician burnout.

Twin Health

Precision health platform, used by doctors to safely reverse diabetes and chronic diseases.

Array Behavioral Care

Provider of telepsychiatry and telebehavioral health services.

Source: Nasdaq Private Market Tape D™